Research > ETFs > ETF / ETP Commentary > 

Leveraged ETFs: From Megacaps to Micro Trends

Single-stock leveraged ETFs were unusual when they first arrived in the U.S. market just four years ago. Today, it might be hard to find a stock without one. Issuers are aggressively pushing beyond megacap tech into niche equities, pre-IPO registrations, and even experimenting with leverage levels and frequency.Key Takeaways: Single-stock leveraged ETFs are expanding rapidly beyond tech megacaps into specialized sub-sectors, pre-IPO registrations, and niche equities. ETFs are evolving beyond daily 2x leverage toward potential intraday hourly resets and higher multipliers, compounding short-term trading risk. Rapid issuer launches are driving market saturation, leading to lower average assets per fund and accelerated product closures. Single-Stock ETFs Initially Started With Familiar NamesLeveraged ETFs have been around for years, but U.S.-listed leveraged and inverse ETFs tied to individual stocks did not arrive until July 2022. AXS Investments launched the first U.S. suite in July 2022, with eight funds providing leveraged or inverse daily exposure to stocks like Tesla (TSLA) and Nvidia (NVDA) — mostly large, familiar companies with actively traded shares and significant investor interest. That initial group provided a relatively straightforward use case: investors with a strong short-term view on a popular stock could amplify that view without trading options. Soon after, Direxion launched its 2x Tesla products, cementing TSLA as a cornerstone underlying asset. The Direxion Daily TSLA Bull 2X ETF (TSLL A-), launched in August 2022, is still one of the most popular leveraged ETFs. It currently has the second highest liquidity among the U.S.-listed ETF universe measured by 30-day average volume. From the beginning, regulators expressed caution regarding both concentration and compounding risk. The SEC emphasized that daily compounding causes performance to diverge significantly if held beyond the intended time period. A 2X daily Nvidia ETF, for instance, targets twice the performance over a single trading day rather than over an extended holding period.From Large Caps to Niche StocksWhile trading volume initially focused around major tech giants, aggressive issuer competition rapidly expanded the universe into micro caps and other niche stocks. Recent regulatory filings demonstrate leveraged products reaching into more obscure areas like drones, photonics, and crypto miners. By targeting specialized names, issuers are turning thematic trends into trading tools. Recent examples include the Leverage Shares 2x Long CRML Daily ETF (CRMU) for Critical Metals (CRML), the Defiance Daily Target 2X Long RCAT ETF (RCAX) for drone maker Red Cat (RCAT), the Defiance Daily Target 2X Long POET ETF (POEL) for photonics company POET Technologies (POET), and the GraniteShares 2x Long BTDR Daily ETF (BTDL) for bitcoin miner Bitdeer Technologies (BTDR),.While There Are Closures, Many New Names Also AppearDespite rapid product launches in leveraged ETFs accounting for a dominant share of recent ETF debuts, the market has become crowded. Average assets for some new funds are often only a few million, while closures of low-asset single-stock products have accelerated year over year. But new ones are still appearing. For example, Defiance recently closed leveraged funds on stocks like DraftKings (DKNG) and Rocket Companies (RKT) while soon after filing for hourly-reset products on stocks like Sk Hynix (SKHY) and Advanced Micro Devices (AMD). This highlights that these products often open and close as demand for the underlying security ebbs and flows, but closures do not necessarily mean a lack of demand for the broader space.The ETF Race Is Starting Before the IPOIssuers are now positioning leveraged products well ahead of public trading debuts. Ahead of recent IPOs like Space Exploration Technologies (SPCX), issuers had 2x funds ready to launch immediately alongside the underlying equity. The largest is currently the Leverage Shares 2X Long SPCX Daily ETF (SPCH), although there are now around 14 leveraged funds focused on SpaceX. That strategy has now extended to high-profile private companies like OpenAI, Anthropic, and Canva, where issuers are preemptively filing for leveraged exposure. Rather than waiting to see whether a newly public company develops enough trading interest to support a leveraged ETF, many issuers are making that decision in advance so they can move quickly if demand materializes.The Next Potential Wave: More leverage and Shorter resetsCompetition is also occurring through the amount and frequency of leverage. T-REX has filed its proposed 4x daily ETFs tied to companies including Microsoft (MSFT) and Palantir (PLTR), which would target four times the daily performance of their underlying stocks if they ultimately come to market. More recently, Defiance has taken a different approach by proposing 16 ETFs with hourly rather than daily resets. The lineup includes familiar names such as Nvidia and Tesla but also more specialized exposures including Applied Optoelectronics (AAOI) and Nebius (NBIS). The proposed funds would divide the trading day into six intraday execution periods, seeking 2x exposure over each individual period rather than targeting 2x for the entire trading day. The same compounding characteristics that investors already need to understand with daily-reset leveraged ETFs could occur several times within a single session.Bottom Line:Single-stock leveraged ETFs are evolving rapidly. In around four years, U.S. single-stock ETFs have moved from daily leveraged exposure to a handful of large, heavily traded companies toward small and niche stocks, pre-IPO registrations, and new structures. While single-stock leveraged ETFs are becoming faster, narrower and more specialized, there are also a growing number of closures. For more news, information, and strategy, visit ETFDB.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.